CCL5 and cancer: Remarkably, an additional role of NK cells in the immune response to cancer has been demonstrated by recent publications that showed NK cells controlling the levels of intratumoral cross-presenting cDC1s, by expression of FLT3 Ligand [92] and chemokines, such as CCL5 (RANTES) and XCL-1/XCL-2 [91,93].